Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Timeless circadian regulator (TIMELESS) is a highly conserved protein that plays a dual role in coordinating the circadian clock and maintaining genomic integrity during DNA replication. It interacts with the TIMELESS-interacting protein (TIPIN) to form a complex that associates with the replisome, where it stabilizes replication forks and ensures efficient DNA synthesis, particularly under conditions of replication stress [1, 3]. Beyond its role in the S-phase checkpoint and DNA damage response, TIMELESS is a core component of the mammalian circadian oscillator, helping to regulate the timing of physiological processes [1, 4]. In many human malignancies, TIMELESS is significantly overexpressed and correlates with advanced tumor stage, poor prognosis, and resistance to platinum-based chemotherapies [2, 4]. Consequently, it has emerged as a compelling therapeutic target; inhibiting TIMELESS via antisense oligonucleotides or small molecules can disrupt replication fork stability and sensitize cancer cells to DNA-damaging agents [4]. Sources: [1] UniProt Consortium. "Timeless circadian regulator (Human)." Q9UNS1. [2] Chi, L., et al. "TIMELESS: A potential oncogene and therapeutic target in cancer." (2018). [3] Leman, A. R., & Noguchi, E. "The replication fork: understanding the eukaryotic replication machinery and the challenges to genome stability." (2013). [4] Zhang, Y., et al. "The role of TIMELESS in cancer: from mechanism to therapy." (2021).
Antisense-mediated mRNA degradation leading to reduced protein expression; disruption of the TIMELESS-TIPIN complex to induce replication fork collapse.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Timeless circadian regulator (TIMELESS) (TIMELESS).